ID   PARP4_HUMAN             Reviewed;        1724 AA.
AC   Q9UKK3; O75903; Q14682; Q5QNZ9; Q9H1M6;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 3.
DT   28-JUN-2023, entry version 205.
DE   RecName: Full=Protein mono-ADP-ribosyltransferase PARP4 {ECO:0000305};
DE            EC=2.4.2.- {ECO:0000269|PubMed:25043379};
DE   AltName: Full=193 kDa vault protein {ECO:0000303|PubMed:10477748};
DE   AltName: Full=ADP-ribosyltransferase diphtheria toxin-like 4 {ECO:0000303|PubMed:20106667};
DE            Short=ARTD4 {ECO:0000303|PubMed:20106667};
DE   AltName: Full=PARP-related/IalphaI-related H5/proline-rich {ECO:0000303|PubMed:10100603};
DE            Short=PH5P {ECO:0000303|PubMed:10100603};
DE   AltName: Full=Poly [ADP-ribose] polymerase 4 {ECO:0000303|PubMed:20106667};
DE            Short=PARP-4 {ECO:0000303|PubMed:20106667};
DE   AltName: Full=Vault poly(ADP-ribose) polymerase {ECO:0000303|PubMed:10477748};
DE            Short=VPARP {ECO:0000303|PubMed:10477748};
GN   Name=PARP4 {ECO:0000303|PubMed:20106667, ECO:0000312|HGNC:HGNC:271};
GN   Synonyms=ADPRTL1 {ECO:0000303|PubMed:10644454}, KIAA0177
GN   {ECO:0000303|PubMed:8724849}, PARPL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 306-319, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND VARIANT THR-899.
RX   PubMed=10477748; DOI=10.1083/jcb.146.5.917;
RA   Kickhoefer V.A., Siva A.C., Kedersha N.L., Inman E.M., Ruland C.,
RA   Streuli M., Rome L.H.;
RT   "The 193 kDa vault protein, VPARP, is a novel poly(ADP-ribose)
RT   polymerase.";
RL   J. Cell Biol. 146:917-928(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS ASN-873; ALA-1265 AND ARG-1280.
RC   TISSUE=Thymus;
RX   PubMed=10644454; DOI=10.1006/geno.1999.6024;
RA   Still I.H., Vince P., Cowell J.K.;
RT   "Identification of a novel gene (ADPRTL1) encoding a potential poly(ADP-
RT   ribosyl)transferase protein.";
RL   Genomics 62:533-536(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ASN-873; ALA-1265 AND
RP   ARG-1280.
RC   TISSUE=Bone marrow;
RX   PubMed=8724849; DOI=10.1093/dnares/3.1.17;
RA   Nagase T., Seki N., Ishikawa K., Tanaka A., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. V. The
RT   coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of
RT   cDNA clones from human cell line KG-1.";
RL   DNA Res. 3:17-24(1996).
RN   [4]
RP   SEQUENCE REVISION.
RA   Ohara O., Nagase T., Kikuno R., Nomura N.;
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [6]
RP   DISCUSSION OF SEQUENCE.
RX   PubMed=10100603; DOI=10.1016/s0014-5793(99)00173-8;
RA   Jean L., Risler J.-L., Nagase T., Coulouarn C., Nomura N., Salier J.-P.;
RT   "The nuclear protein PH5P of the inter-alpha-inhibitor superfamily: a
RT   missing link between poly(ADP-ribose)polymerase and the inter-alpha-
RT   inhibitor family and a novel actor of DNA repair?";
RL   FEBS Lett. 446:6-8(1999).
RN   [7]
RP   ASSOCIATION WITH TEP1.
RX   PubMed=10551828; DOI=10.1074/jbc.274.46.32712;
RA   Kickhoefer V.A., Stephen A.G., Harrington L., Robinson M.O., Rome L.H.;
RT   "Vaults and telomerase share a common subunit, TEP1.";
RL   J. Biol. Chem. 274:32712-32717(1999).
RN   [8]
RP   INTERACTION WITH TEP1.
RX   PubMed=15169895; DOI=10.1128/mcb.24.12.5314-5323.2004;
RA   Liu Y., Snow B.E., Kickhoefer V.A., Erdmann N., Zhou W., Wakeham A.,
RA   Gomez M., Rome L.H., Harrington L.;
RT   "Vault poly(ADP-ribose) polymerase is associated with mammalian telomerase
RT   and is dispensable for telomerase function and vault structure in vivo.";
RL   Mol. Cell. Biol. 24:5314-5323(2004).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-101; SER-1236; SER-1335 AND
RP   SER-1504, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1335, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   NOMENCLATURE.
RX   PubMed=20106667; DOI=10.1016/j.tibs.2009.12.003;
RA   Hottiger M.O., Hassa P.O., Luscher B., Schuler H., Koch-Nolte F.;
RT   "Toward a unified nomenclature for mammalian ADP-ribosyltransferases.";
RL   Trends Biochem. Sci. 35:208-219(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-333; SER-1236 AND SER-1335,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-101, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   FUNCTION.
RX   PubMed=25043379; DOI=10.1038/ncomms5426;
RA   Vyas S., Matic I., Uchima L., Rood J., Zaja R., Hay R.T., Ahel I.,
RA   Chang P.;
RT   "Family-wide analysis of poly(ADP-ribose) polymerase activity.";
RL   Nat. Commun. 5:4426-4426(2014).
RN   [16]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-1476, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- FUNCTION: Mono-ADP-ribosyltransferase that mediates mono-ADP-
CC       ribosylation of target proteins. {ECO:0000269|PubMed:25043379}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-aspartyl-[protein] + NAD(+) = 4-O-(ADP-D-ribosyl)-L-
CC         aspartyl-[protein] + nicotinamide; Xref=Rhea:RHEA:54424, Rhea:RHEA-
CC         COMP:9867, Rhea:RHEA-COMP:13832, ChEBI:CHEBI:17154,
CC         ChEBI:CHEBI:29961, ChEBI:CHEBI:57540, ChEBI:CHEBI:138102;
CC         Evidence={ECO:0000305};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-glutamyl-[protein] + NAD(+) = 5-O-(ADP-D-ribosyl)-L-
CC         glutamyl-[protein] + nicotinamide; Xref=Rhea:RHEA:58224, Rhea:RHEA-
CC         COMP:10208, Rhea:RHEA-COMP:15089, ChEBI:CHEBI:17154,
CC         ChEBI:CHEBI:29973, ChEBI:CHEBI:57540, ChEBI:CHEBI:142540;
CC         Evidence={ECO:0000305};
CC   -!- SUBUNIT: Component of the vault ribonucleoprotein particle, at least
CC       composed of MVP, PARP4 and one or more vault RNAs (vRNAs)
CC       (PubMed:10477748). Interacts with TEP1 (PubMed:10551828,
CC       PubMed:15169895). {ECO:0000269|PubMed:10477748,
CC       ECO:0000269|PubMed:10551828, ECO:0000269|PubMed:15169895}.
CC   -!- INTERACTION:
CC       Q9UKK3; Q9Q2G4: ORF; Xeno; NbExp=3; IntAct=EBI-2623021, EBI-6248094;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10477748}. Nucleus
CC       {ECO:0000269|PubMed:10477748}. Cytoplasm, cytoskeleton, spindle
CC       {ECO:0000269|PubMed:10477748}. Note=Also found in the nucleus,
CC       associated with mitotic spindles. {ECO:0000269|PubMed:10477748}.
CC   -!- TISSUE SPECIFICITY: Widely expressed; the highest levels are in the
CC       kidney; also detected in heart, placenta, lung, liver, skeletal muscle,
CC       spleen, leukocytes and pancreas. {ECO:0000269|PubMed:10477748}.
CC   -!- SIMILARITY: Belongs to the ARTD/PARP family. {ECO:0000305}.
CC   -!- CAUTION: Was initially thought to mediate to mediate poly-ADP-
CC       ribosylation of proteins (PubMed:10477748). However, it was later shown
CC       to act as a mono-ADP-ribosyltransferase (PubMed:25043379).
CC       {ECO:0000269|PubMed:10477748, ECO:0000269|PubMed:25043379}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA11494.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF158255; AAD47250.1; -; mRNA.
DR   EMBL; AF057160; AAC62491.1; -; mRNA.
DR   EMBL; D79999; BAA11494.2; ALT_INIT; mRNA.
DR   EMBL; AL359763; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS9307.1; -.
DR   RefSeq; NP_006428.2; NM_006437.3.
DR   RefSeq; XP_011533234.1; XM_011534932.2.
DR   AlphaFoldDB; Q9UKK3; -.
DR   SMR; Q9UKK3; -.
DR   BioGRID; 106653; 48.
DR   IntAct; Q9UKK3; 25.
DR   MINT; Q9UKK3; -.
DR   STRING; 9606.ENSP00000371419; -.
DR   BindingDB; Q9UKK3; -.
DR   ChEMBL; CHEMBL6142; -.
DR   DrugCentral; Q9UKK3; -.
DR   CarbonylDB; Q9UKK3; -.
DR   GlyCosmos; Q9UKK3; 3 sites, 1 glycan.
DR   GlyGen; Q9UKK3; 4 sites, 1 O-linked glycan (4 sites).
DR   iPTMnet; Q9UKK3; -.
DR   PhosphoSitePlus; Q9UKK3; -.
DR   SwissPalm; Q9UKK3; -.
DR   BioMuta; PARP4; -.
DR   DMDM; 308153574; -.
DR   EPD; Q9UKK3; -.
DR   jPOST; Q9UKK3; -.
DR   MassIVE; Q9UKK3; -.
DR   MaxQB; Q9UKK3; -.
DR   PaxDb; Q9UKK3; -.
DR   PeptideAtlas; Q9UKK3; -.
DR   ProteomicsDB; 84811; -.
DR   Antibodypedia; 1562; 226 antibodies from 27 providers.
DR   DNASU; 143; -.
DR   Ensembl; ENST00000381989.4; ENSP00000371419.3; ENSG00000102699.6.
DR   GeneID; 143; -.
DR   KEGG; hsa:143; -.
DR   MANE-Select; ENST00000381989.4; ENSP00000371419.3; NM_006437.4; NP_006428.2.
DR   UCSC; uc001upl.4; human.
DR   AGR; HGNC:271; -.
DR   CTD; 143; -.
DR   DisGeNET; 143; -.
DR   GeneCards; PARP4; -.
DR   HGNC; HGNC:271; PARP4.
DR   HPA; ENSG00000102699; Low tissue specificity.
DR   MIM; 607519; gene.
DR   neXtProt; NX_Q9UKK3; -.
DR   OpenTargets; ENSG00000102699; -.
DR   PharmGKB; PA24591; -.
DR   VEuPathDB; HostDB:ENSG00000102699; -.
DR   eggNOG; KOG1037; Eukaryota.
DR   GeneTree; ENSGT00940000160555; -.
DR   HOGENOM; CLU_001437_0_0_1; -.
DR   InParanoid; Q9UKK3; -.
DR   OMA; PHKGTMP; -.
DR   OrthoDB; 11548at2759; -.
DR   PhylomeDB; Q9UKK3; -.
DR   TreeFam; TF329720; -.
DR   BRENDA; 2.4.2.30; 2681.
DR   PathwayCommons; Q9UKK3; -.
DR   Reactome; R-HSA-197264; Nicotinamide salvaging.
DR   Reactome; R-HSA-9683610; Maturation of nucleoprotein.
DR   Reactome; R-HSA-9694631; Maturation of nucleoprotein.
DR   SignaLink; Q9UKK3; -.
DR   BioGRID-ORCS; 143; 11 hits in 1156 CRISPR screens.
DR   ChiTaRS; PARP4; human.
DR   GeneWiki; PARP4; -.
DR   GenomeRNAi; 143; -.
DR   Pharos; Q9UKK3; Tchem.
DR   PRO; PR:Q9UKK3; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; Q9UKK3; protein.
DR   Bgee; ENSG00000102699; Expressed in rectum and 99 other tissues.
DR   Genevisible; Q9UKK3; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; NAS:UniProtKB.
DR   GO; GO:1990904; C:ribonucleoprotein complex; NAS:UniProtKB.
DR   GO; GO:0005876; C:spindle microtubule; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0019899; F:enzyme binding; IDA:MGI.
DR   GO; GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:1990404; F:NAD+-protein ADP-ribosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0016779; F:nucleotidyltransferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006974; P:DNA damage response; NAS:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; TAS:ProtInc.
DR   GO; GO:0006954; P:inflammatory response; IMP:UniProtKB.
DR   GO; GO:0036211; P:protein modification process; IDA:UniProtKB.
DR   GO; GO:0051972; P:regulation of telomerase activity; IDA:BHF-UCL.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; NAS:UniProtKB.
DR   CDD; cd17726; BRCT_PARP4_like; 1.
DR   CDD; cd01437; parp_like; 1.
DR   Gene3D; 3.90.228.10; -; 1.
DR   Gene3D; 3.40.50.10190; BRCT domain; 1.
DR   Gene3D; 1.20.142.10; Poly(ADP-ribose) polymerase, regulatory domain; 1.
DR   Gene3D; 3.40.50.410; von Willebrand factor, type A domain; 1.
DR   InterPro; IPR001357; BRCT_dom.
DR   InterPro; IPR036420; BRCT_dom_sf.
DR   InterPro; IPR031273; PARP4.
DR   InterPro; IPR012317; Poly(ADP-ribose)pol_cat_dom.
DR   InterPro; IPR004102; Poly(ADP-ribose)pol_reg_dom.
DR   InterPro; IPR036616; Poly(ADP-ribose)pol_reg_dom_sf.
DR   InterPro; IPR013694; VIT.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   PANTHER; PTHR46530; PROTEIN MONO-ADP-RIBOSYLTRANSFERASE PARP4; 1.
DR   PANTHER; PTHR46530:SF1; PROTEIN MONO-ADP-RIBOSYLTRANSFERASE PARP4; 1.
DR   Pfam; PF00533; BRCT; 1.
DR   Pfam; PF00644; PARP; 1.
DR   Pfam; PF08487; VIT; 1.
DR   Pfam; PF00092; VWA; 1.
DR   SMART; SM00292; BRCT; 1.
DR   SMART; SM00609; VIT; 1.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF56399; ADP-ribosylation; 1.
DR   SUPFAM; SSF52113; BRCT domain; 1.
DR   SUPFAM; SSF47587; Domain of poly(ADP-ribose) polymerase; 1.
DR   SUPFAM; SSF53300; vWA-like; 1.
DR   PROSITE; PS50172; BRCT; 1.
DR   PROSITE; PS51060; PARP_ALPHA_HD; 1.
DR   PROSITE; PS51059; PARP_CATALYTIC; 1.
DR   PROSITE; PS51468; VIT; 1.
DR   PROSITE; PS50234; VWFA; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Cytoskeleton; Direct protein sequencing; Glycosyltransferase;
KW   Methylation; NAD; Nucleotidyltransferase; Nucleus; Phosphoprotein;
KW   Reference proteome; Ribonucleoprotein; Transferase.
FT   CHAIN           1..1724
FT                   /note="Protein mono-ADP-ribosyltransferase PARP4"
FT                   /id="PRO_0000211330"
FT   DOMAIN          1..94
FT                   /note="BRCT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00033"
FT   DOMAIN          242..370
FT                   /note="PARP alpha-helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00398"
FT   DOMAIN          369..573
FT                   /note="PARP catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00397"
FT   DOMAIN          607..735
FT                   /note="VIT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00801"
FT   DOMAIN          876..1046
FT                   /note="VWFA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00219"
FT   REGION          97..123
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1408..1452
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1562..1724
FT                   /note="Interaction with the major vault protein"
FT                   /evidence="ECO:0000269|PubMed:10477748"
FT   MOTIF           19..25
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   MOTIF           1237..1249
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        1408..1422
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         101
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         333
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1236
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         1335
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   MOD_RES         1476
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         1504
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   VARIANT         81
FT                   /note="I -> V (in dbSNP:rs35200240)"
FT                   /id="VAR_056645"
FT   VARIANT         122
FT                   /note="S -> N (in dbSNP:rs9578751)"
FT                   /id="VAR_056646"
FT   VARIANT         215
FT                   /note="F -> Y (in dbSNP:rs9318600)"
FT                   /id="VAR_056647"
FT   VARIANT         792
FT                   /note="P -> L (in dbSNP:rs4986818)"
FT                   /id="VAR_056648"
FT   VARIANT         873
FT                   /note="S -> N (in dbSNP:rs7140044)"
FT                   /evidence="ECO:0000269|PubMed:10644454,
FT                   ECO:0000269|PubMed:8724849"
FT                   /id="VAR_056649"
FT   VARIANT         899
FT                   /note="A -> T (in dbSNP:rs2275660)"
FT                   /evidence="ECO:0000269|PubMed:10477748"
FT                   /id="VAR_056650"
FT   VARIANT         991
FT                   /note="K -> R (in dbSNP:rs34689435)"
FT                   /id="VAR_056651"
FT   VARIANT         1012
FT                   /note="V -> I (in dbSNP:rs9581043)"
FT                   /id="VAR_056652"
FT   VARIANT         1253
FT                   /note="S -> T (in dbSNP:rs4986822)"
FT                   /id="VAR_056653"
FT   VARIANT         1265
FT                   /note="G -> A (in dbSNP:rs1050110)"
FT                   /evidence="ECO:0000269|PubMed:10644454,
FT                   ECO:0000269|PubMed:8724849"
FT                   /id="VAR_016090"
FT   VARIANT         1280
FT                   /note="G -> R (in dbSNP:rs13428)"
FT                   /evidence="ECO:0000269|PubMed:10644454,
FT                   ECO:0000269|PubMed:8724849"
FT                   /id="VAR_016091"
FT   CONFLICT        519
FT                   /note="S -> P (in Ref. 1; AAD47250)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        897
FT                   /note="Q -> E (in Ref. 2; AAC62491 and 3; BAA11494)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        936
FT                   /note="M -> A (in Ref. 2; AAC62491 and 3; BAA11494)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        936
FT                   /note="M -> T (in Ref. 1; AAD47250)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1065
FT                   /note="V -> A (in Ref. 1; AAD47250 and 2; AAC62491)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1080
FT                   /note="L -> R (in Ref. 1; AAD47250, 2; AAC62491 and 3;
FT                   BAA11494)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1108
FT                   /note="R -> C (in Ref. 1; AAD47250, 2; AAC62491 and 3;
FT                   BAA11494)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1328
FT                   /note="P -> T (in Ref. 1; AAD47250, 2; AAC62491 and 3;
FT                   BAA11494)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1331
FT                   /note="A -> T (in Ref. 1; AAD47250, 2; AAC62491 and 3;
FT                   BAA11494)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1394
FT                   /note="S -> A (in Ref. 1; AAD47250, 2; AAC62491 and 3;
FT                   BAA11494)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1459
FT                   /note="S -> Y (in Ref. 1; AAD47250, 2; AAC62491 and 3;
FT                   BAA11494)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1550
FT                   /note="L -> P (in Ref. 1; AAD47250, 2; AAC62491 and 3;
FT                   BAA11494)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1555
FT                   /note="V -> L (in Ref. 1; AAD47250)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1564
FT                   /note="I -> T (in Ref. 1; AAD47250, 2; AAC62491 and 3;
FT                   BAA11494)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1656
FT                   /note="A -> P (in Ref. 1; AAD47250, 2; AAC62491 and 3;
FT                   BAA11494)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1724 AA;  192595 MW;  DCA1DD4C001EA22F CRC64;
     MVMGIFANCI FCLKVKYLPQ QQKKKLQTDI KENGGKFSFS LNPQCTHIIL DNADVLSQYQ
     LNSIQKNHVH IANPDFIWKS IREKRLLDVK NYDPYKPLDI TPPPDQKASS SEVKTEGLCP
     DSATEEEDTV ELTEFGMQNV EIPHLPQDFE VAKYNTLEKV GMEGGQEAVV VELQCSRDSR
     DCPFLISSHF LLDDGMETRR QFAIKKTSED ASEYFENYIE ELKKQGFLLR EHFTPEATQL
     ASEQLQALLL EEVMNSSTLS QEVSDLVEMI WAEALGHLEH MLLKPVNRIS LNDVSKAEGI
     LLLVKAALKN GETAEQLQKM MTEFYRLIPH KGTMPKEVNL GLLAKKADLC QLIRDMVNVC
     ETNLSKPNPP SLAKYRALRC KIEHVEQNTE EFLRVRKEVL QNHHSKSPVD VLQIFRVGRV
     NETTEFLSKL GNVRPLLHGS PVQNIVGILC RGLLLPKVVE DRGVQRTDVG NLGSGIYFSD
     SLSTSIKYSH PGETDGTRLL LICDVALGKC MDLHEKDFSL TEAPPGYDSV HGVSQTASVT
     TDFEDDEFVV YKTNQVKMKY IIKFSMPGDQ IKDFHPSDHT ELEEYRPEFS NFSKVEDYQL
     PDAKTSSSTK AGLQDASGNL VPLEDVHIKG RIIDTVAQVI VFQTYTNKSH VPIEAKYIFP
     LDDKAAVCGF EAFINGKHIV GEIKEKEEAQ QEYLEAVTQG HGAYLMSQDA PDVFTVSVGN
     LPPKAKVLIK ITYITELSIL GTVGVFFMPA TVAPWQQDKA LNENLQDTVE KICIKEIGTK
     QSFSLTMSIE MPYVIEFIFS DTHELKQKRT DCKAVISTME GSSLDSSGFS LHIGLSAAYL
     PRMWVEKHPE KESEACMLVF QPDLDVDLPD LASESEVIIC LDCSSSMEGV TFLQAKQIAL
     HALSLVGEKQ KVNIIQFGTG YKELFSYPKH ITSNTMAAEF IMSATPTMGN TDFWKTLRYL
     SLLYPARGSR NILLVSDGHL QDESLTLQLV KRSRPHTRLF ACGIGSTANR HVLRILSQCG
     AGVFEYFNAK SKHSWRKQIE DQMTRLCSPS CHSVSVKWQQ LNPDVPEALQ APAQVPSLFL
     NDRLLVYGFI PHCTQATLCA LIQEKEFRTM VSTTELQKTT GTMIHKLAAR ALIRDYEDGI
     LHENETSHEM KKQTLKSLII KLSKENSLIT QFTSFVAVEK RDENESPFPD IPKVSELIAK
     EDVDFLPYMS WQGEPQEAVR NQSLLASSEW PELRLSKRKH RKIPFSKRKM ELSQPEVSED
     FEEDGLGVLP AFTSNLERGG VEKLLDLSWT ESCKPTATEP LFKKVSPWET STSSFFPILA
     PAVGSYLPPT ARAHSPASLS FASYRQVASF GSAAPPRQFD ASQFSQGPVP GTCADWIPQS
     ASCPTGPPQN PPSSPYCGIV FSGSSLSSAQ SAPLQHPGGF TTRPSAGTFP ELDSPQLHFS
     LPTDPDPIRG FGSYHPSASS PFHFQPSAAS LTANLRLPMA SALPEALCSQ SRTTPVDLCL
     LEESVGSLEG SRCPVFAFQS SDTESDELSE VLQDSCFLQI KCDTKDDSIL CFLEVKEEDE
     IVCIQHWQDA VPWTELLSLQ TEDGFWKLTP ELGLILNLNT NGLHSFLKQK GIQSLGVKGR
     ECLLDLIATM LVLQFIRTRL EKEGIVFKSL MKMDDASISR NIPWAFEAIK QASEWVRRTE
     GQYPSICPRL ELGNDWDSAT KQLLGLQPIS TVSPLHRVLH YSQG
//
